๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This is the first human study to use X-396 (ensartinib), a drug being devel...
Status
Completed
Location
City of Hope National Med Ctr
Start Date
2012-06
Trial ID
NCT01625234
Treatments Being Tested
To assess treatment effectiveness and safety of oral X-396 capsule (Ensarti...
Status
Unknown
Location
Chest hospital affiliated to Shanghai jiao tong university
Start Date
2018-06-15
Trial ID
NCT03608007
Treatments Being Tested
After the use of second-generation ALK-TKI drug resistance, about 50% of ti...
Status
Unknown
Location
Sun Yat-sen University
Start Date
2021-12-01
Trial ID
NCT05178511
Treatments Being Tested
This phase II, umbrella trial study directed by next generation sequencing ...
Status
Unknown
Location
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology
Start Date
2018-07-09
Trial ID
NCT03574402
This randomized, active-controlled, multicenter, open-label, Phase II study...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-01-01
Trial ID
NCT05186506
Treatments Being Tested
This phase II Pediatric MATCH treatment trial studies how well ensartinib w...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2018-04-17
Trial ID
NCT03213652
The main purpose of the study is to evaluate safety and efficacy of X-396(E...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-09-28
Trial ID
NCT03215693
Treatments Being Tested